Shares of PureTech Health plc (LON:PRTC - Get Free Report) crossed below its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of GBX 129.90 ($1.73) and traded as low as GBX 122.60 ($1.63). PureTech Health shares last traded at GBX 123 ($1.63), with a volume of 1,071,889 shares changing hands.
PureTech Health Price Performance
The firm has a market cap of £389.89 million, a P/E ratio of -5.33 and a beta of 1.02. The business has a 50-day simple moving average of GBX 129.23 and a 200 day simple moving average of GBX 145.42. The company has a debt-to-equity ratio of 45.82, a quick ratio of 2.51 and a current ratio of 3.68.
About PureTech Health
(
Get Free Report)
PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule.
Read More
Before you consider PureTech Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and PureTech Health wasn't on the list.
While PureTech Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
